We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Butterfly Network, Inc. (BFLY - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Butterfly Network, Inc. is a member of the Medical sector. This group includes 1019 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Butterfly Network, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BFLY's full-year earnings has moved 11.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, BFLY has moved about 39.8% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of 11.7% on a year-to-date basis. This shows that Butterfly Network, Inc. is outperforming its peers so far this year.
One other Medical stock that has outperformed the sector so far this year is Brainsway Ltd. Sponsored ADR (BWAY - Free Report) . The stock is up 17% year-to-date.
In Brainsway Ltd. Sponsored ADR's case, the consensus EPS estimate for the current year increased 166.7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Breaking things down more, Butterfly Network, Inc. is a member of the Medical Info Systems industry, which includes 41 individual companies and currently sits at #69 in the Zacks Industry Rank. Stocks in this group have lost about 10.6% so far this year, so BFLY is performing better this group in terms of year-to-date returns.
In contrast, Brainsway Ltd. Sponsored ADR falls under the Medical - Products industry. Currently, this industry has 88 stocks and is ranked #84. Since the beginning of the year, the industry has moved +13.3%.
Investors interested in the Medical sector may want to keep a close eye on Butterfly Network, Inc. and Brainsway Ltd. Sponsored ADR as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Butterfly Network, Inc. (BFLY - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Butterfly Network, Inc. is a member of the Medical sector. This group includes 1019 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Butterfly Network, Inc. is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BFLY's full-year earnings has moved 11.9% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, BFLY has moved about 39.8% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of 11.7% on a year-to-date basis. This shows that Butterfly Network, Inc. is outperforming its peers so far this year.
One other Medical stock that has outperformed the sector so far this year is Brainsway Ltd. Sponsored ADR (BWAY - Free Report) . The stock is up 17% year-to-date.
In Brainsway Ltd. Sponsored ADR's case, the consensus EPS estimate for the current year increased 166.7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Breaking things down more, Butterfly Network, Inc. is a member of the Medical Info Systems industry, which includes 41 individual companies and currently sits at #69 in the Zacks Industry Rank. Stocks in this group have lost about 10.6% so far this year, so BFLY is performing better this group in terms of year-to-date returns.
In contrast, Brainsway Ltd. Sponsored ADR falls under the Medical - Products industry. Currently, this industry has 88 stocks and is ranked #84. Since the beginning of the year, the industry has moved +13.3%.
Investors interested in the Medical sector may want to keep a close eye on Butterfly Network, Inc. and Brainsway Ltd. Sponsored ADR as they attempt to continue their solid performance.